Atlas Trials

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

Clinical trial NCT02823145 · COMPLETED

Trial details

NCT number
NCT02823145
Sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dravet Syndrome
Start date
2016-06-08
Primary completion
2023-01-27
Enrollment
375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.